Table 1 Baseline characteristics
From: Coronary artery calcification in patients with advanced chronic kidney disease
|  | Overall (n = 146) |
|---|---|
Age (yr, mean ± SD) | 60.49 ± 16.39 |
Sex, n (%) | Â |
male | 92 (63.0%) |
female | 54 (37.0%) |
Primary renal disease, n (%) | Â |
CGN | 57 (39.0%) |
DN | 41 (28.1%) |
HTN | 34 (23.3%) |
Others | 14 (9.6%) |
RRT, n (%) | Â |
HD | 83 (56.8%) |
PD | 37 (25.3%) |
no | 26 (17.8%) |
Laboratory analysis | Â |
HGB | 96.5 (84.75, 109.25) |
CRP | 7.80 (1.30, 25.18) |
ALB | 34.04 ± 4.96 |
Ca | 2.35 ± 0.22 |
P | 1.68 (1.26, 2.27) |
Bone metabolic markers | Â |
iPTH | 284.35 (108.55, 983.73) |
βCTx | 1861.50 (1133.25, 4610.75) |
N-MID | 176.85 (59.90, 275.03) |
25[OH]D | 13.80 (7.55, 22.52) |
P1NP | 239.90 (139.53, 1200.00) |
Cardiac ultrasound | Â |
LA (mm) | 38.91 ± 6.32 |
RV (mm) | 22.00 (20.00, 23.00) |
EF (%) | 63 (57, 67) |
Calcification score M(Q1,Q3) | 216.00 (1.00, 909.75) |
n(%) | Â |
0 | 35 (23.97%) |
1-100 | 26 (17.81%) |
101–400 | 29 (19.86%) |
> 400 | 56 (38.36%) |